ALXA - and any number of other bios...there is no news-driven reason for the recent fall. It is mostly the overall market. High risk, speculative biotechs always take more of a hit when the risk off trade is in effect. Just look back to March 2009 and look at the pps of any small cap bio.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.